Prevention of heterotopic ossification after total hip replacement: A prospective comparison of indomethacin and salmon calcitonin in 60 patients

Authors

  • Izge Günal
  • Bülent Hazer
  • Sinan Seber
  • Erol Göktürk
  • Akin Turgut
  • Nusret Köse

DOI:

https://doi.org/10.1080/000164701753532781

Abstract

We did a prospective consecutive study of prophylaxis for heterotopic ossification (HO) comparing indomethacin (100 mg/day) and salmon calcitonin (3 MRC-U/kg/day) for 14 days. Each group consisted of 30 patients. 19 patients in the indomethacin group and 2 in the calcitonin group developed HO. We conclude that use of calcitonin in the prophylaxis of HO after total hip replacement is more effective than indomethacin.

Downloads

Download data is not yet available.

Downloads

Published

2001-01-01

How to Cite

Günal, I., Hazer, B., Seber, S., Göktürk, E., Turgut, A., & Köse, N. (2001). Prevention of heterotopic ossification after total hip replacement: A prospective comparison of indomethacin and salmon calcitonin in 60 patients. Acta Orthopaedica, 72(5), 467–469. https://doi.org/10.1080/000164701753532781

Issue

Acta Orthopaedica, Volume 72, Issue 5 (2001)

Section

Articles

License

Acta Orthopaedica (Scandinavica) content is available freely online as from volume 1, 1930. The journal owner owns the copyright for all material published until volume 80, 2009. As of June 2009, the journal has however been published fully Open Access, meaning the authors retain copyright to their work. As of June 2009, articles have been published under CC-BY-NC or CC-BY licenses, unless otherwise specified.
 
Crossref
Scopus
Google Scholar
Europe PMC

PlumX (by Elsevier) is an altmetrics platform that tracks and visualizes the online attention, usage, captures, citations, and social media engagement.